Virgin Galactic Had More Redemptions Than You Think
by Kristi Marvin on 2019-10-29 at 9:57am

Early this morning, Social Capital Hedosophia Acquisition Corp., now Virgin Galactic (SPCE), filed an 8-K, post-closing of their combination.  It’s was a big filing with no less than 16 exhibits included, but if you scrolled to the bottom of the 8-K, there is a link to the unaudited pro forma financial information. And if you then read through that document, you would FINALLY find the results of the shareholder vote.  And shockingly, there were 12,106,110 shareholders that redeemed this past Wednesday. That means ~$125 million was removed from Trust. And if we include the number of redemptions from their extension vote, that totals 15,877,288 shares.

Given that post-closing of the Virgin Galactic deal, the share price zoomed into the $12.00 range, there are probably more than a few redeemers kicking themselves right now. Weak hands indeed. Although, it’s still strange that the long-only crowd opted to only “get involved” post vote and buy near $11.00 or $12.00 when they could have bought a little below trust value (~$10.39) just a few days prior.

So the higher than expected number of redemptions is probably the result of a combination of SPAC investors hanging around too long waiting to see if the share price would go higher and long-only investors waiting for the combination to close.  SPAC investors WANTED to sell above trust, but the long-only crowd wasn’t there right before the vote.  At that point, remaining SPAC investors got stuck and had to redeem.

Regardless, I doubt the IPOA and Virgin Galactic teams are sweating it with a share price in the $11.00 range. This was still a hugely successful deal.  You can find the redemption results HERE (with a little bit of scrolling).


SIDE NOTE: We’re back on “So-Called” Watch.  If you recall, I’ve mentioned before the tendency for financial journalists to reference SPACS as “a so-called blank check company”.  It’s not “so-called”. It is called.  However, there must be some sort of rule or template out there that when a SPAC is referenced, you MUST use this term.  And while you would think that with a high profile deal like Virgin Galactic, people would finally “get” what a SPACs is, nope.  To wit: yesterday’s article on Bloomberg .  And if you’re so inclined, you can go HEREHEREHERE and HERE to see this “so-called” phrase used repeatedly.

 

Recent Posts
by Nicholas Alan Clayton on 2024-03-27 at 1:31pm

News and Rumors CNBC: Former WeWork (OTC Pink:WEWKQ) founder Adam Neumann has offered to buy back control of the company for $500 million but has yet to secure the necessary financing. WeWork went public with BowX in October 2021. PR: Satellite telecom firm Spire Global (NYSE:SPIR) has signed an agreement to build and launch two...

by Nicholas Alan Clayton on 2024-03-27 at 11:38am

Bannix (NASDAQ:BNIX) has entered into a definitive agreement to combine with VisionWave Technologies for $30 million. The combined company is expected to trade on the Nasdaq once the deal is completed with an initial outside date of September 14. Transaction Overview Bannix has about $17 million in its trust after seeing 77.4% of its shares...

by Nicholas Alan Clayton on 2024-03-27 at 7:33am

At the SPAC of Dawn Much of the attention yesterday was on tracking the swings of the newly-completed Trump Media (NASDAQ:DJT) deal with the FT going as far to suggest it may “make SPACs great again.” Not all of the day’s data points were on the positive side of the ledger, however. IB Acquisition Corp....

by Nicholas Alan Clayton on 2024-03-26 at 1:52pm

News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...

by Nicholas Alan Clayton on 2024-03-26 at 11:51am

APx (NASDAQ:APXI) has entered into a definitive agreement to combine with precision medicine firms OmnigenicsAI and MultiplAI at an enterprise value $340 million. Once combined, these companies will offer DNA tests to consumers linked to predictive insights on their nutritional and genomic health. The combined company is expected to trade on the Nasdaq under the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved